NEW YORK – October 14, 2026 -- New Yorkers comparing Medicare Advantage options can now look at a plan that has held a 4-Star overall rating from the Centers for Medicare & Medicaid Services (CMS) two years running: MetroPlusHealth.
Three MetroPlusHealth plans carry the 4-Star rating
The rating applies to the MetroPlus Advantage Plan (HMO D-SNP), the MetroPlus Platinum Plan (HMO) and MetroPlus UltraCare (HMO D-SNP). In the 2027 Medicare Star Ratings, MetroPlusHealth earned 4 Stars for Part C and 4.5 Stars for Part D prescription drug coverage. That builds on its 4-Star Medicare Advantage rating for 2026.
Medicare scores plans on a 5-Star scale using 2025–2026 data
Medicare evaluates plans each year across a broad range of quality and performance measures, and the ratings help beneficiaries compare plans when choosing coverage. The 2027 Star Ratings are primarily based on data collected during 2025–2026. MetroPlusHealth reports strong results in clinical care, medication management and member experience.
CEO Dr. Talya Schwartz described the result as "meaningful, sustained progress." Chief Medical Officer Dr. Sanjiv Shah said the plan's focus is helping members manage chronic conditions, stay on their medications and make informed decisions about their care.
The Advantage Plan adds a $3,120 Flex Card, rides and hearing aid funds
The MetroPlus Advantage Plan (HMO D-SNP) includes $3,120 annually in Flex Card benefits. It also covers 50 one-way rides to and from medical appointments and $2,000 per year toward hearing aids.
NYC Health + Hospitals ties extend access across all five boroughs
MetroPlusHealth's Medicare Advantage plans are closely integrated with NYC Health + Hospitals, which the company calls the nation's largest municipal health care system. That link supports coordinated care and access to providers in all five boroughs, with services tailored to New York City's diverse and multilingual communities.